These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 733550)

  • 21. The haemodynamic effects of labetalol, ketanserin and a placebo at the end of a NLA. A double blind study.
    Barvais L; Capouet V; d'Hollander A
    Acta Anaesthesiol Belg; 1984; 35 Suppl():453-6. PubMed ID: 6516754
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of labetalol as a moderate hypotensive agent in otological operations--plasma concentrations after intravenous administration.
    Kanto J; Pakkanen A; Allonen H; Kleimola T; Mäntylä R
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):191-4. PubMed ID: 7390669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.
    Lund-Johansen P
    Br J Clin Pharmacol; 1979; 8(Suppl 2):107S-111S. PubMed ID: 583322
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of the hemodynamic effects of labetalol and sodium nitroprusside in patients undergoing carotid endarterectomy.
    Geniton DJ
    AANA J; 1990 Aug; 58(4):281-7. PubMed ID: 2399780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-hypertensive action, time of onset and effects on carbohydrate metabolism of labetalol.
    Andersson O; Berglund G; Hansson L
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):757-61. PubMed ID: 1032990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic effects of acute and long-term treatment with labetalol.
    Lysbo Svendsen T; Rasmussen S; Nielsen PE; Hartling O; Trap-Jensen J
    Acta Med Scand Suppl; 1979; 625():49-53. PubMed ID: 285575
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of labetalol on plasma catecholamines at rest and during increased sympathetic activity.
    Carlsen JE; Trap-Jensen J; Svendsen TL; Nielsen PE; Rasmussen S; Christensen NJ
    Postgrad Med J; 1980; 56 Suppl 2():43-8. PubMed ID: 7433342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.
    Lund-Johansen P; Bakke OM
    Br J Clin Pharmacol; 1979 Feb; 7(2):169-74. PubMed ID: 760749
    [No Abstract]   [Full Text] [Related]  

  • 29. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Postgrad Med J; 1980; 56 Suppl 2():21-6. PubMed ID: 7433338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemodynamic effects of intravenous labetalol in hypertensive patients with obstructive coronary heart disease complicated by acute myocardial infarction of recent origin.
    Mulac KD; Meryn S
    Eur Heart J; 1983 Jun; 4(6):398-405. PubMed ID: 6617686
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antihypertensive effects of labetalol administered parenterally and orally].
    Nicolaescu V; Serban-Pârâu G; Ionescu P; Nuţă M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(5):405-12. PubMed ID: 6151227
    [No Abstract]   [Full Text] [Related]  

  • 32. Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol.
    Baum T; Watkins RW; Sybertz EJ; Vemulapalli S; Pula KK; Eynon E; Nelson S; Vliet GV; Glennon J; Moran RM
    J Pharmacol Exp Ther; 1981 Aug; 218(2):444-52. PubMed ID: 7252843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute hemodynamic effect of labetalol in severe hypertension].
    Omvik P; Lund-Johansen P
    Tidsskr Nor Laegeforen; 1980 Nov; 100(33):1971-4. PubMed ID: 7456057
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
    Rosei EA; Brown JJ; Lever AF; Robertson AS; Robertson JI; Trust PM
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):809-15. PubMed ID: 990158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemodynamic effects of labetalol in patients with acute myocardial infarct and systemic arterial hypertension].
    Cantelli I; Lombardi G; Naccarella F; Pavesi PC; Bracchetti D
    G Ital Cardiol; 1981; 11(1):110-8. PubMed ID: 7239092
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical pharmacology of labetalol.
    Richards DA; Prichard BN
    Br J Clin Pharmacol; 1979; 8(Suppl 2):89S-93S. PubMed ID: 43165
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical pharmacology of hypertension: amelioration of left ventricular performance by treatment with labetalol.
    Belogi M; Ansuini R; Pupita G; Campolucci G; Pupita F
    Int J Clin Pharmacol Res; 1984; 4(5):385-7. PubMed ID: 6519853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of a monoamine oxidase inhibitor-tyramine hypertensive emergency with intravenous labetalol.
    Abrams JH; Schulman P; White WB
    N Engl J Med; 1985 Jul; 313(1):52. PubMed ID: 4000229
    [No Abstract]   [Full Text] [Related]  

  • 39. Rate of onset of hypotensive response with oral labetalol [proceedings].
    Breckenridge AM; Macnee CM; Orme NL; Richards DA; Sterlin MJ
    Br J Clin Pharmacol; 1977 Jun; 4(3):388P. PubMed ID: 901712
    [No Abstract]   [Full Text] [Related]  

  • 40. Experience with labetalol in hypertension.
    Bolli P; Waal-Manning J; Wood AJ; Simpson FO
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.